Rivera-Robles Jose, Alam Komal, Abdelmonem Ahmed, Edwards Audrene, Abdelreheim Ahmad, Mathai Susan K, Duncan Michael, Naik Chetan
Baylor University Medical Center, Dallas, Texas.
Texas A&M University, College of Medicine, Bryan, Texas.
JHLT Open. 2025 Feb 14;8:100228. doi: 10.1016/j.jhlto.2025.100228. eCollection 2025 May.
Comparison of thermodilution (TD) and indirect Fick (iFick) methods of cardiac output (CO) measurement has not been well described in patients with World Health Organization (WHO) group 3 pulmonary hypertension (PH).
We conducted a single-center retrospective chart review of 96 patients with WHO group 3 PH who underwent lung transplantation. For comparison, 32 WHO group 1 pulmonary arterial hypertension patients who were followed in our PH clinic during the same period were also included in the study.
TThere was a significant difference between iFick CO and TD CO (5.93+/ -1.5 versus 5.46+/ -1.8 liter/minute, =0.0061) in WHO group 3 PH. Pulmonary vascular resistance (PVR) calculated using iFick and TD-CO values also differed significantly. TD-PVR was more strongly associated with measures of poor outcomes after lung transplant.
iFick-CO and TD-CO can be significantly different in WHO group 3 PH. In cases of discrepancy between iFick and TD-COs, TD-CO correlates better with clinical outcomes after lung transplantation.
在世界卫生组织(WHO)3组肺动脉高压(PH)患者中,心输出量(CO)测量的热稀释法(TD)和间接菲克法(iFick)的比较尚未得到充分描述。
我们对96例接受肺移植的WHO 3组PH患者进行了单中心回顾性病历审查。为了进行比较,同期在我们的PH诊所随访的32例WHO 1组肺动脉高压患者也纳入了研究。
在WHO 3组PH中,iFick法测得的CO与TD法测得的CO之间存在显著差异(5.93±1.5对5.46±1.8升/分钟,P = 0.0061)。使用iFick和TD-CO值计算的肺血管阻力(PVR)也有显著差异。TD-PVR与肺移植后不良结局的指标相关性更强。
在WHO 3组PH中,iFick-CO和TD-CO可能存在显著差异。在iFick和TD-CO结果不一致的情况下,TD-CO与肺移植后的临床结局相关性更好。